Despite the near perfect storm of branded competitors temporarily sidelined by production disruptions and Perrigo Co. PLC’s strong line-up of new product launches in fiscal 2012, the firm’s consumer health care business’ operating income remained essentially flat, causing some concern among financial analysts.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?